Prelude Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,726
| Closed | -$8K | – | 1745 |
|
|
2022
Q2 | $8K | Buy |
+10,726
| New | +$8K | ﹤0.01% | 1360 |
|
|
2020
Q4 | – | Sell |
-300
| Closed | -$3K | – | 1469 |
|
|
2020
Q3 | $3K | Buy |
300
+200
| +200% | +$2K | ﹤0.01% | 1235 |
|
|
2020
Q2 | $1K | Sell |
100
-600
| -86% | -$6K | ﹤0.01% | 1266 |
|
|
2020
Q1 | $6K | Sell |
700
-200
| -22% | -$1.71K | ﹤0.01% | 804 |
|
|
2019
Q4 | $9K | Buy |
900
+200
| +29% | +$2K | ﹤0.01% | 1253 |
|
|
2019
Q3 | $7K | Buy |
700
+200
| +40% | +$2K | ﹤0.01% | 1045 |
|
|
2019
Q2 | $6K | Buy |
+500
| New | +$6K | ﹤0.01% | 1110 |
|